LAVACCHI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.849
AS - Asia 2.282
EU - Europa 2.265
SA - Sud America 199
AF - Africa 59
OC - Oceania 27
Totale 7.681
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.789
RU - Federazione Russa 880
CN - Cina 674
SG - Singapore 672
IT - Italia 588
HK - Hong Kong 287
VN - Vietnam 197
KR - Corea 187
IE - Irlanda 159
BR - Brasile 155
PL - Polonia 114
SE - Svezia 105
FR - Francia 92
DE - Germania 86
FI - Finlandia 78
IN - India 60
JP - Giappone 44
ID - Indonesia 39
NL - Olanda 38
GB - Regno Unito 37
JO - Giordania 36
CA - Canada 31
AU - Australia 27
BD - Bangladesh 21
AT - Austria 19
MX - Messico 18
CH - Svizzera 16
ES - Italia 14
IQ - Iraq 14
NG - Nigeria 13
ZA - Sudafrica 11
AR - Argentina 10
PK - Pakistan 10
UA - Ucraina 9
CI - Costa d'Avorio 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
EC - Ecuador 7
BJ - Benin 6
GR - Grecia 6
PE - Perù 6
PH - Filippine 6
VE - Venezuela 6
MA - Marocco 5
AL - Albania 4
CO - Colombia 4
EG - Egitto 4
TR - Turchia 4
BE - Belgio 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
KE - Kenya 3
LT - Lituania 3
OM - Oman 3
UZ - Uzbekistan 3
BB - Barbados 2
CR - Costa Rica 2
HN - Honduras 2
KZ - Kazakistan 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
TW - Taiwan 2
UY - Uruguay 2
AZ - Azerbaigian 1
BH - Bahrain 1
BS - Bahamas 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KW - Kuwait 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 7.681
Salva come PNG Salva come JPEG
Città #
Santa Clara 740
Singapore 495
Ashburn 466
Hong Kong 259
Hefei 202
Seoul 186
San Jose 171
Dublin 157
Florence 112
Warsaw 110
Fairfield 92
Council Bluffs 81
Beijing 80
Chandler 75
Moscow 62
Milan 60
Buffalo 56
The Dalles 56
Ho Chi Minh City 55
Los Angeles 55
Woodbridge 48
Munich 47
Dallas 46
Lauterbourg 43
Hanoi 42
Tokyo 39
Altamura 36
Helsinki 35
Jakarta 35
Lawrence 35
Seattle 35
Cambridge 34
Houston 33
New York 33
Shanghai 31
Paris 29
Boardman 26
Melbourne 26
Wilmington 26
Ann Arbor 24
Brescia 24
Lappeenranta 24
Kent 22
Princeton 20
Rome 19
Mumbai 18
Boston 17
Guangzhou 17
Vienna 17
Turku 16
Chicago 15
London 15
Bengaluru 13
Haiphong 13
São Paulo 13
Abuja 12
Bern 12
Frankfurt am Main 12
Orem 10
Toronto 10
Mexico City 9
Abidjan 8
Dhaka 8
Johannesburg 8
Pune 8
Redondo Beach 8
Amsterdam 7
Bologna 7
Bremen 7
Montreal 7
Naples 7
Phoenix 7
San Diego 7
San Francisco 7
Tianjin 7
Chennai 6
Cotonou 6
Curitiba 6
Dong Ket 6
Medford 6
Rio de Janeiro 6
Stockholm 6
Turin 6
Vũng Tàu 6
West Jordan 6
Charlotte 5
Falls Church 5
Hillsboro 5
Nuremberg 5
Ottawa 5
Amandola 4
Ancona 4
Arezzo 4
Atlanta 4
Barcelona 4
Brooklyn 4
Bắc Ninh 4
Clifton 4
Da Nang 4
Douglasville 4
Totale 4.829
Salva come PNG Salva come JPEG
Nome #
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 279
Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions 247
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 246
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience 218
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 216
Metastatic intracranial solitary fibrous tumors/hemangiopericytomas: description of two cases with radically different behaviors and review of the literature 213
Evaluation of RAS mutational status through BEAMing assay to monitor disease progression of metastatic colorectal cancer: a case report 200
KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation 199
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy 199
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy 197
Stable disease in a patient with metastatic leiomyosarcoma treated with trabectedin 195
Abiraterone plus prednisone or enzalutamide in patients with metastatic castration-resistant prostate cancer: is a question of quality? 195
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 192
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 178
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population 178
Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study 174
Results of the observational prospective RealFLOT study 174
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 173
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI 163
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer 162
Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience 159
Vinorelbine in non-small cell lung cancer: Real-World data from a single institution experience 159
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients 154
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population 153
Liquid biopsy in colorectal cancer: No longer young, but not yet old 151
TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination 150
Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experience 149
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM) 148
Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma 148
Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas 143
Immune checkpoint inhibitors in the treatment of renal cancer: Current state and future perspective 138
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer 138
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer. 127
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer 127
REBECA trial: A new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer 125
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 124
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients 123
Tumor-Agnostic Treatment for Cancer: When How is Better than Where 121
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study 118
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population 117
Primary pleural epithelioid hemangioendothelioma: case report and review of the literature 116
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 102
MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel Immunotherapy 99
Treatment Strategy for Oligometastatic Gastric Cancer: Brief Considerations 91
Electronic nicotine delivery systems (ENDS): not still ready to put on END 85
The emerging HER2 landscape in colorectal cancer: the key to unveil the future treatment algorithm? 78
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 69
A Snapshot from the Italian Clinical Practice Regarding Efficacy and Utility Rate of Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: The RealBLADDER Study 47
Immune checkpoint inhibitors in the first-line treatment of esophageal squamous cell carcinoma: Minireview for a big shift 32
Beneath the surface of colorectal cancer: Unmasking the evolving nature of (Neo)RAS 30
Transcriptomic analysis on pancreatic adenocarcinoma patients uncovers KRAS-mediated PPAR pathway alteration 29
Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: Results from the MAVERIC Phase II Trial (1499 WORDS MAIN TEXT) 25
Prediction of Microsatellite Instability in Colorectal Cancer Using Two Internally Validated Radiomic Models 22
Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study 20
Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment 19
Radiomics-based prediction of microsatellite instability in colorectal cancer: a non-invasive approach to treatment stratification 19
Navigating Disappearing Liver Metastases in Colorectal Cancer: A Review of Surgical and Non-Surgical Approaches 16
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population 14
Radiomics on 177Lu-DOTATATE Posttreatment Scans: Feasibility, Preprocessing Optimization, and Planar-SPECT Comparison 14
Microbiome dysbiosis and KRAS-driven tumorigenesis in pancreatic cancer: implications for immune checkpoint inhibitors efficacy 13
Ivosidenib for IDH1‐Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real‐World Study 12
Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real‐world results from a multicenter and multinational study 12
Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer 12
Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers 11
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC‐D Index 10
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population 9
Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab 8
Impact of Antibiotic Therapy in Patients with Cholangiocarcinoma Treated with Chemoimmunotherapy 6
Totale 7.790
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.087
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 0 18 27
2021/2022161 7 4 14 4 3 7 4 28 8 14 24 44
2022/2023571 33 108 30 36 20 101 78 48 61 14 20 22
2023/2024579 15 21 45 53 50 53 28 121 20 67 48 58
2024/20252.671 79 214 146 430 628 359 71 156 141 101 160 186
2025/20263.350 402 452 415 266 368 130 417 229 281 301 89 0
Totale 7.790